Abstract
Venomous snakes not native to the USA exist in zoos, aquariums, serpentariums, academic, public and quasi-public institutions, and private collections, which may or may not be legal, may or may not be known to healthcare providers in their region, and for which there may or may not be preparations for an envenomation. Envenomations by nonnative species pose challenges to every element of the healthcare system. A variety of response systems have been developed in the USA and other countries. A preexisting response system can optimize patient outcomes and lessen stresses on health delivery systems. The specifics of an optimal systematic nonnative envenomation response program will differ by geographic region and healthcare system considerations but should address common issues encountered in these cases regarding provider unfamiliarity, antivenom acquisition and expert consultation. In the USA, a system of antivenom availability through zoos, strategic antivenom geographic placement, information resources through the Antivenom Index and regional poison centers, as well as a national expert consultant panel constitute the current response system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Antivenom Index. https://avi.pharmacy.arizona.edu/a/index#top. Accessed 12 May 2016.
Calvete JJ, Sanz L, Pla D, Lomonte B, Gutiérrez JM. Omics meets biology: application to the design and preclinical assessment of antivenoms. Toxins (Basel). 2014;6(12):3388–405.
Carbajal-Saucedo A, Floriano RS, Dal Belo CA, Olvera-Rodríguez A, Alagón A, Rodrigues-Simioni L. Neuromuscular activity of Micrurus laticollaris (Squamata: Elapidae) venom in vitro. Toxins (Basel). 2014;6(1):359–70.
Card W, Roberts DT. Incidence of bites from venomous reptiles in North American zoos. Herpetol Rev. 1996;27:15–6.
Chani M, Abouzahir A, Larréché S, Mion G. Pulmonary embolism in the context of severe envenomation by a Moroccan viper. Bull Soc Pathol Exot. 2012;105(3):162–5.
Chew MS, Guttormsen AB, Metzsch C, Jahr J. Exotic snake bite: a challenge for the Scandinavian anesthesiologist? Acta Anaesthesiol Scand. 2003;47(2):226–9.
Clinical Toxinology Resources. http://www.toxinology.com/. Accessed 16 May 2016.
Coulson JM, Cooper G, Krishna C, Thompson JP. Snakebite enquiries to the UK National Poisons Information Service: 2004–2010. Emerg Med J. 2013;30(11):932–4.
Darsonval A, Boels D, Clerc MA, De Haro L, Penot-Ragon C, Moal F, Quistinic P, Lourdais O, Harry P. Creation and organization of an antivenomous serum bank in France. Presse Med. 2010;39(9):865–70.
de Haro L. Management of snakebites in France. Toxicon. 2012;60(4):712–8.
Department of Health and Human Services (DHHS)/Health Resources and Services Administration (HRSA) Grants #H4BHS00938, #U4BHS08565. https://www.hrsa.gov/index.html
Dijkman MA, van der Zwan CW, de Vries I. Establishment and first experiences of the National Serum Depot in the Netherlands. Toxicon. 2012;60(4):700–5.
Fahmi L, Makran B, Pla D, Sanz L, Oukkache N, Lkhider M, Harrison RA, Ghalim N, Calvete JJ. Venomics and antivenomics profiles of North African Cerastes cerastes and C. vipera populations reveals a potentially important therapeutic weakness. J Proteomics. 2012;75(8):2442–53.
Gutiérrez JM, Tsai WC, Pla D, Solano G, Lomonte B, Sanz L, Angulo Y, Calvete JJ. Preclinical assessment of a polyspecific antivenom against the venoms of Cerrophidion sasai, Porthidium nasutum and Porthidium ophryomegas: insights from combined antivenomics and neutralization assays. Toxicon. 2013;64:60–9.
Habib AG, Gebi UI, Onyemelukwe GC. Snake bite in Nigeria. Afr J Med Med Sci. 2001;30(3):171–8.
Hart AJ, Isbister GK, O’Donnell P, Williamson NA, Hodgson WC. Species differences in the neuromuscular activity of post-synaptic neurotoxins from two Australian black snakes (Pseudechis porphyriacus and Pseudechis colletti). Toxicol Lett. 2013;219(3):262–8.
Ivanyi C, Altimari W. Venomous reptile bites in academic research. Herp Rev. 2004;35(1):49–50.
Kitchens CS, Van Mierop LH. Envenomation by the Eastern coral snake (Micrurus fulvius fulvius). A study of 39 victims. JAMA. 1987;258(12):1615–1618.
Lavonas EJ, Ruha AM, Banner W, Bebarta V, Bernstein JN, Bush SP, Kerns 2nd WP, Richardson WH, Seifert SA, Tanen DA, Curry SC, Dart RC, Rocky Mountain Poison and Drug Center, Denver Health and Hospital Authority. Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop. BMC Emerg Med. 2011;11:2.
Leclerc T, Debien B, Perez JP, Petit MP, Lenoir B. Mamba envenomation in mainland France: management of exotic envenomations needs rethinking. Ann Fr Anesth Reanim. 2008;27(4):323–5.
Machiah DK, Gowda TV. Purification of a post-synaptic neurotoxic phospholipase A2 from Naja naja venom and its inhibition by a glycoprotein from Withania somnifera. Biochimie. 2006;88(6):701–10.
Maduwage K, Isbister GK. Current treatment for venom-induced consumption coagulopathy resulting from snakebite. PLoS Negl Trop Dis. 2014;8(10):e3220.
Malbranque S, Piercecchi-Marti MD, Thomas L, Barbey C, Courcier D, Bucher B, Ridarch A, Smadja D, Warrell DA. Fatal diffuse thrombotic microangiopathy after a bite by the “Fer-de-Lance” pit viper (Bothrops lanceolatus) of Martinique. Am J Trop Med Hyg. 2008;78(6):856–61.
McNally J, Boesen K, Boyer L. Toxicologic information resources for reptile envenomations. Vet Clin North Am Exot Anim Pract. 2008;11(2):389–401.
Minton SA. Bites by non-native venomous snakes in the United States. Wilderness Environ Med. 1996;7(4):297–303.
Nirthanan S, Charpantier E, Gopalakrishnakone P, Gwee MC, Khoo HE, Cheah LS, Kini RM, Bertrand D. Neuromuscular effects of candoxin, a novel toxin from the venom of the Malayan krait (Bungarus candidus). Br J Pharmacol. 2003;139(4):832–44.
O’Leary MA, Kornhauser RS, Hodgson WC, Isbister GK. An examination of the activity of expired and mistreated commercial Australian antivenoms. Trans R Soc Trop Med Hyg. 2009;103(9):937–42.
Othong R, Sheikh S, Alruwaili N, Gorodetsky R, Morgan BW, Lock B, Kazzi ZN. Exotic venomous snakebite drill. Clin Toxicol (Phila). 2012;50(6):490–6.
Panfoli I, Calzia D, Ravera S, Morelli A. Inhibition of hemorrhagic snake venom components: old and new approaches. Toxins (Basel). 2010;2(4):417–27.
Russell FE. Snake venom poisoning. Great Neck: Lippincott; 1980. p. 345–94.
Schaper A, Desel H, Ebbecke M, De Haro L, Deters M, Hentschel H, Hermanns-Clausen M, Langer C. Bites and stings by exotic pets in Europe: an 11 year analysis of 404 cases from Northeastern Germany and Southeastern France. Clin Toxicol (Phila). 2009;47(1):39–43.
Seifert SA, Keyler D, Isbister G, McNally J, Martin TG. ACMT Position Statement: Institutions housing venomous animals. J Med Toxicol. 2006;2(3):118–9.
Seifert SA, Oakes JA, Boyer LV. Toxic Exposure Surveillance System (TESS)-based characterization of U.S. non-native venomous snake exposures, 1995–2004. Clin Toxicol (Phila). 2007;45(5):571–8.
Seifert SA, White J, Currie BJ. Commentary: pressure bandaging for North American snake bite? No! J Med Toxicol. 2011;7:324–6.
Sennwald G. [Toxic necrosis following a bite by Naja nigricollis, a therapeutic challenge]. [Article in French]. Schweiz Med Wochenschr. 1992;122(18):696–701.
Silva TP, Moura VM, Souza MC, Santos VN, Silva KA, Mendes MG, Nunez CV, Almeida PD, Lima ES, Mourão RH, Dos-Santos MC. Connarus favosus Planch: an inhibitor of the hemorrhagic activity of Bothrops atrox venom and a potential antioxidant and antibacterial agent. J Ethnopharmacol. 2016;183:166–75.
Stadelmann M, Ionescu M, Chilcott M, Berney JL, Gétaz L. Exotic snake bites in Switzerland. Rev Med Suisse. 2010;6(248):969–72.
U.S. FDA Expiration date guidance. http://www.fda.gov/RegulatoryInformation/Guidances/ucm125127.htm
U.S. FDA Extension of Coral Snake AV. http://www.fda.gov/biologicsbloodvaccines/safetyavaialability/ucm445083.htm
U.S. FDA. Information on the use of antivenoms. http://www.fda.gov/BiologicsBloodVaccines/DevelopmentApprovalProcess/InvestigationalNewDrugINDorDeviceExemptionIDEProcess/ucm094321.htm. Accessed 16 May 2016.
Vital Brazil O, Vieira RJ. Neostigmine in the treatment of snake accidents caused by Micrurus frontalis: report of two cases (1). Rev Inst Med Trop Sao Paulo. 1996;38(1):61–7.
Wagner P, Townsend E, Barej M, Rödder D, Spawls S. First record of human envenomation by Atractaspis congica Peters, 1877 (Squamata: Atractaspididae). Toxicon. 2009;54(3):368–72.
Warrell DA. Commissioned article: management of exotic snakebites. QJM. 2009;102(9):593–601.
Warrick BJ, Boyer LV, Seifert SA. Non-native (exotic) snake envenomations in the U.S., 2005–2011. Toxins (Basel). 2014;6(10):2899–911.
Warwick C, Steedman C. Injuries, envenomations and stings from exotic pets. J R Soc Med. 2012;105(7):296–9.
Wisniewski MS, Hill RE, Havey JM, Bogdan GM, Dart RC. Australian Tiger Snake (Notechis scutatus) and Mexican Coral Snake (Micruris [sic] species) Antivenoms Prevent Death from United States Coral Snake (Micrurus fulvius fulvius) Venom in a Mouse Model. J Toxicol Clin Toxicol. 2003;41(1):7–10.
Wood A, Schauben J, Thundiyil J, Kunisaki T, Sollee D, Lewis-Younger C, Bernstein J, Weisman R. Review of Eastern coral snake (Micrurus fulvius fulvius) exposures managed by the Florida Poison Information Center Network: 1998–2010. Clin Toxicol (Phila). 2013;51(8):783–788. https://doi.org/10.3109/15563650.2013.828841.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media B.V., part of Springer Nature
About this entry
Cite this entry
Seifert, S.A. (2018). Exotic Envenomation in the United States. In: Vogel, CW., Seifert, S., Tambourgi, D. (eds) Clinical Toxinology in Australia, Europe, and Americas. Toxinology. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7438-3_70
Download citation
DOI: https://doi.org/10.1007/978-94-017-7438-3_70
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-7436-9
Online ISBN: 978-94-017-7438-3
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences